Come up with a name for your new list and we'll add to it:
Antidote Therapeutics raised a round of funding on April 02, 2017. Investors include
National Institutes of Health.
Antidote Therapeutics is assessing the protein properties of a novel nicotine degrading enzyme and its suitability for use as a smoking cessation treatment.…